Showing 19,881 - 19,900 results of 102,596 for search '(( 50 ((nn decrease) OR (mean decrease)) ) OR ( 5 ((fold decrease) OR (a decrease)) ))', query time: 1.08s Refine Results
  1. 19881

    Pain scores for each condition in Experiment 2 (<i>n</i> = 26). by Miki Matsumuro (12647119)

    Published 2022
    “…Moreover, the baseline was measured without the HMD prior to all experimental conditions. A negative score indicates that perceived pain decreased more than the baseline evaluation, whereas a positive score denotes that perceived pain increased more than the baseline evaluation. …”
  2. 19882
  3. 19883

    Effect of Ac-SDKP on cardiac rupture incidence, mortality rate, and infarct size in myocardial infarction. by Pablo Nakagawa (4794402)

    Published 2018
    “…<p>Out of 95 mice analyzed at 7 days post-MI, 38 died from cardiac rupture, and 5 died from other causes. In myocardial infarction, Ac-SDKP decreased A) incidence of cardiac rupture from 51.0% (vehicle treated) to 27.3% (Ac-SDKP treated) and B) mortality from 56.9% (vehicle treated) to 31.8% (Ac-SDKP treated). …”
  4. 19884
  5. 19885

    DataSheet_1_The miR-33a-5p/CROT axis mediates ovarian cancer cell behaviors and chemoresistance via the regulation of the TGF-β signal pathway.pdf by Xin Li (51274)

    Published 2022
    “…Thus, targeting the miR-33a-5p/CROT axis may have clinical potential for the treatment of patients with OC.…”
  6. 19886
  7. 19887

    Presentation3_Analysis of B-cell receptor repertoire to evaluate the immunogenicity of SARS-CoV-2 RBD mRNA vaccine: MAFB-7256a (DS-5670d).pptx by Goh Ohji (5205629)

    Published 2024
    “…<p>A monovalent Omicron XBB.1.5 mRNA RBD analogue vaccine, MAFB-7256a (DS-5670d), was newly developed and approved in Japan in the Spring of 2024 for the prevention of COVID-19. …”
  8. 19888

    Presentation2_Analysis of B-cell receptor repertoire to evaluate the immunogenicity of SARS-CoV-2 RBD mRNA vaccine: MAFB-7256a (DS-5670d).pptx by Goh Ohji (5205629)

    Published 2024
    “…<p>A monovalent Omicron XBB.1.5 mRNA RBD analogue vaccine, MAFB-7256a (DS-5670d), was newly developed and approved in Japan in the Spring of 2024 for the prevention of COVID-19. …”
  9. 19889

    Presentation1_Analysis of B-cell receptor repertoire to evaluate the immunogenicity of SARS-CoV-2 RBD mRNA vaccine: MAFB-7256a (DS-5670d).pptx by Goh Ohji (5205629)

    Published 2024
    “…<p>A monovalent Omicron XBB.1.5 mRNA RBD analogue vaccine, MAFB-7256a (DS-5670d), was newly developed and approved in Japan in the Spring of 2024 for the prevention of COVID-19. …”
  10. 19890

    Image_5_GPCR19 Regulates P2X7R-Mediated NLRP3 Inflammasomal Activation of Microglia by Amyloid β in a Mouse Model of Alzheimer’s Disease.tif by Jahirul Islam (11280516)

    Published 2022
    “…Furthermore, TDCA enhanced phagocytosis of Aβ and decreased the number of Aβ plaques in the brains of 5x Familial Alzheimer’s disease (5xFAD) mice. …”
  11. 19891

    Supplemental figures for manuscript entitled: Tumor Suppressors RBL1 and PTEN are Epigenetically Silenced in IPF Mesenchymal Progenitor Cells by a CD44/Brg1/PRMT5 Regulatory Comple... by Craig Henke (9406202)

    Published 2024
    “…<p dir="ltr">The IPF lung contains mesenchymal progenitor cells (MPCs) that display durable activation of oncogenic signaling and cell-autonomous fibrogenicity <i>in vivo</i>. Prior work identified a CD44/Brg1/PRMT5 nuclear regulatory module in IPF MPCs that increased expression of genes positively regulating pluripotency and self-renewal. …”
  12. 19892
  13. 19893
  14. 19894

    Image_1_v1_Case Report: J-Shaped External Fixator for Treatment of Mayo Type II Olecranon Fractures – A Novel Surgical Technique and Report of Clinical Applications.tif by Yue Tian (1765825)

    Published 2022
    “…Operative time and intraoperative blood loss were decreased by 41.3% and 64.6%, respectively, in J-EF patients than those in a comparable group treated by TBW. …”
  15. 19895

    The prognostic value of the neutrophil-percentage-to-albumin ratio for all-cause and cardiovascular mortality in chronic kidney disease stages G3a to G5: insights from NHANES 2003–... by Jialing Rao (20354623)

    Published 2025
    “…<p>Patients with chronic kidney disease (CKD) stages G3a to G5 frequently experience heightened systemic inflammation and nutritional loss. …”
  16. 19896
  17. 19897

    Effect of <i>CYP6d5</i> knockdown in Drosophila caffeine metabolism. by Alexandra Coelho (691773)

    Published 2015
    “…<p>A- The comparison of the normalized quantities of caffeine metabolites reveals a dramatic decrease of theobromine combined with a substantial increase of M2 in <i>CYP6d5</i> silenced flies (ds<i>CYP6d5</i>/<i>Actin</i>-GAL4) compared to the two transgenic parental controls (<i>Actin</i>-GAL4/+, ds<i>CYP6d5</i>/+). …”
  18. 19898

    DataSheet_1_Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Periphe... by Klaudia Kwiatkowski (9118247)

    Published 2020
    “…In parallel, administration of cenicriviroc decreased the expression of CCR2 in the spinal cord and CCR5 in DRG. …”
  19. 19899

    Cytoplasmic Location of α1A Voltage-Gated Calcium Channel C-Terminal Fragment (Ca<sub>v</sub>2.1-CTF) Aggregate Is Sufficient to Cause Cell Death by Makoto Takahashi (386772)

    Published 2013
    “…<div><p>The human α<sub>1A</sub> voltage-dependent calcium channel (Ca<sub>v</sub>2.1) is a pore-forming essential subunit embedded in the plasma membrane. …”
  20. 19900

    DataSheet_2_Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Periphe... by Klaudia Kwiatkowski (9118247)

    Published 2020
    “…In parallel, administration of cenicriviroc decreased the expression of CCR2 in the spinal cord and CCR5 in DRG. …”